Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria

被引：0
|
作者：
Patrick, Stephanie A. [1 ]
Dabal, Tracey D. [1 ]
Jackson, Christopher D. [1 ]
Halalau, Alexandra [1 ]
机构：
[1] UTHSC Internal Med Residency, Memphis, TN 38163 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2021年 / 36卷 / 09期
关键词：
D O I：
10.1007/s11606-021-06871-w
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：2915 / 2917
页数：3
相关论文
共 50 条
  • [1] Dapagliflozin Improves the Clinical Outcomes of Patients with Chronic Kidney Disease and Albuminuria
    Stephanie A. Patrick
    Tracey D. Dabal
    Christopher D. Jackson
    Journal of General Internal Medicine, 2021, 36 : 2915 - 2917
  • [2] Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease
    McMurray, John J. V.
    Wheeler, David C.
    Stefansson, Bergur V.
    Jongs, Niels
    Postmus, Douwe
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Held, Claes
    Hou, Fan-Fan
    Mann, Johannes F. E.
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna Maria
    Heerspink, Hiddo J. L.
    CIRCULATION, 2021, 143 (05) : 438 - 448
  • [3] Dapagliflozin and Blood Pressure in Patients with Chronic Disease and Albuminuria
    Heerspink, Hiddo J. L.
    Provenzano, Michele
    Vart, Priya
    Jongs, Niels
    Correa-Rotter, Ricardo
    Rossing, Peter
    Mark, Patrick B.
    Pecoits-Filho, Roberto
    McMurray, John J., V
    Langkilde, Anna Maria
    Wheeler, David C.
    Toto, Robert B.
    Chertow, Glenn M.
    AMERICAN HEART JOURNAL, 2024, 270 : 125 - 135
  • [4] Dapagliflozin in Patients with Chronic Kidney Disease
    Heerspink, Hiddo J. L.
    Stefansson, Bergur V.
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan-Fan
    Mann, Johannes F. E.
    McMurray, John J. V.
    Lindberg, Magnus
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna-Maria
    Wheeler, David C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1436 - 1446
  • [5] Albuminuria lowering effect of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease a randomised cross-over clinical trial
    Provenzano, M.
    Heerspink, H. J. L.
    Puchades, M.
    Garofalo, C.
    Jongs, N.
    Adreucci, M.
    De Nicola, L.
    Gorriz, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S281 - S281
  • [6] Dapagliflozin reduces urinary kidney injury biomarkers in chronic kidney disease irrespective of albuminuria level
    Park, Kootae
    Kwon, Soon Hyo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [7] Dapagliflozin Reduces Urinary Kidney Injury Biomarkers in Chronic Kidney Disease Irrespective of Albuminuria Level
    Cho, Junghyun
    Doo, Seung Whan
    Song, Nayoung
    Lee, Minsul
    Lee, Haekyung
    Kim, Hyongnae
    Jeon, Jin Seok
    Noh, Hyunjin
    Kwon, Soon Hyo
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1441 - 1449
  • [8] Dapagliflozin reduces urinary kidney injury biomarkers in chronic kidney disease irrespective of albuminuria level
    Park, Kootae
    Kwon, Soon Hyo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2398 - I2398
  • [9] Dapagliflozin in Patients with Chronic Kidney Disease REPLY
    Heerspink, Hiddo J. L.
    Langkilde, Anna-Maria
    Wheeler, David C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 389 - 390
  • [10] Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-Over Clinical Trial
    Provenzano, Michele
    Puchades, Maria Jesus
    Garofalo, Carlo
    Jongs, Niels
    D'Marco, Luis
    Andreucci, Michele
    De Nicola, Luca
    Gorriz, Jose Luis
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (08): : 1569 - 1580
12345